Self-Management for Head and Neck Lymphedema and Fibrosis [PROMISE Trial]
Start Date
3/29/2024
Completion Date
8/31/2026
Summary
The goal of this study is to evaluate the effectiveness of a standardized lymphedema and fibrosis self-management program (LEF-SMP) to improve LEF self-management and reduce LEF-associated symptom burden, functional deficits, and improve quality of life in head and neck cancer (HNC) survivors.
Detailed Description
In HNC survivors with lymphedema and fibrosis (LEF), the investigators will: 1) compare the effects of in-person LEF-SMP, telehealth LEF-SMP, and usual care on LEF severity; 2) compare the effects of in-person LEF-SMP, telehealth LEF-SMP, and usual care on LEF-related symptom burden, functional impairments, and quality of life; and 3) compare the effects of in-person LEF-SMP, telehealth LEF-SMP, and usual care on LEF-related knowledge, skills, self-efficacy, and self-care adherence.
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
Usual Care
In-Person LEF-SMP
Telehealth LEF-SMP
Conditions
Locations
University of Pennsylvania
Philadelphia, Pennsylvania 19104
United States
Barbara Murphy
Nashville, Tennessee 37232
United States